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INTRODUCTION
Radiodermatitis is a well-known complication of radiotherapy occurring in about 95% of patients. [1, 2] It may also occur due to accidental overexposure to ionizing radiation. Fluoroscopic-induced radiation dermatitis (FIRD) has increasingly been reported coinciding with the rising trend of fluoroscopic-guided diagnostic and therapeutic procedures. The incidence of FIRD is very low and has been estimated to be between 0.01% and 0.001% per procedure, but in a recent report, the incidence was documented as 0.34% per procedure and 0.42% per patient. [3, 4] Radiodermatitis is categorized as acute, subacute, and chronic.
The diagnosis of fluoroscopy-induced chronic radiation dermatitis (FICRD) is often overlooked because of its rarity, late insidious onset, and clinicopathological resemblance to morphea.
We present two cases of FICRD emphasizing the importance of recognizing this entity and highlighting the clinicohistopathological features to avoid misdiagnosis.
CASE REPORTS

Case 1
A 67-year-old, diabetic, male presented with a 12 cm × 15 cm painful, indurated plaque on the left scapular region. It manifested depigmentation and telangiectasia in the center with a small crusted erosion while the periphery was erythematous and hyperpigmented [ Figure 1 ]. The initial dermatologist raised the possibility of morphea and scrofuloderma. However, another dermatologist suspected it to be related to a fluoroscopic procedure. An angioplasty with stent insertion was performed 2.5 years earlier. The procedure was complicated and prolonged. The patient recalled that the stent insertion failed at one hospital and he had to be shifted to another hospital, where only two of the three planned stents could be inserted. One week after the procedure, he experienced pruritus on the back. Two weeks later, it was followed by peeling of skin with redness and discoloration. These initial symptoms almost completely resolved within 6 months. Subsequently, the area acquired a firm texture and ulcerated. The ulcer did not heal over next 2 years despite multiple treatments with antibiotics, topical steroids, and phototherapy. The histopathology revealed a flat epidermis, papillary and reticular dermal sclerosis, loss of appendages, and telangiectatic vessels [ Figure 2a ]. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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Scattered stellate fibroblasts with large hyperchromatic nuclei were noticeable [ Figure 2b ]. A diagnosis of FICRD was made. The patient had a satisfactory resolution with a skin graft.
Case 2
A 58-year-old female presented with a 3-year history of 9" × 3" painful, depigmented-erythematous, indurated, telangiectatic plaque over the right scapular region. A depressed area corresponding to skin grafting done 7 months prior for nonhealing ulcer was seen within the plaque [ Figure 3 ]. The clinical differential diagnoses considered were morphea and dermatofibrosarcoma. Two biopsies were performed and showed similar features as described above for case 1. For 1.5 years, this case remained misdiagnosed as morphea. Although the history of fluoroscopy-guided pacemaker insertion few months before the onset of lesion was known, the significance of this history was missed by dermatologist and pathologist. The clinical photographs and biopsies were re-evaluated, and in view of similarity to case 1, the diagnosis was revised to FICRD.
DISCUSSION
The risk of developing radiodermatitis is proportional to radiation dose, duration of exposure, time interval between exposures, technique, size, and location of the exposed area. The susceptibility also depends on host factors such as light skin color; smoking; body constitution; obesity, overlapping skin folds, and compromised skin integrity; poor nutritional status; autoimmune diseases including connective tissue diseases, diabetes mellitus, and hyperthyroidism; defects in DNA repair genes; and chemotherapeutic agents. [1, 2, 5] Modestly fractioned radiation doses used in conventional radiotherapy are designed to spare the skin, whereas fluoroscopic procedures have no skin-sparing quality, and a high fraction radiation dose may get delivered during a single procedure or as cumulative fractions in repeated procedures. [5, 6] The radiation dose and exposure time depend on the type and complexity of the procedure, with interventional cardiology and neuroradiology procedures being particularly associated with a high dose. In 2005, the Joint Commission defined a fluoroscopic sentinel event as prolonged fluoroscopy resulting in a cumulative peak skin dose of ≥15 Gy to a single field, which may be accumulated through multiple procedures during a period from 6 months to 1 year. [7] Although over two million fluoroscopic procedures are performed yearly, the incidence of FIRD is very low, [8] possibly owing to radiation doses delivered in majority of the procedures being lower than the threshold for skin injury. [9, 10] However, many cases remain unrecognized or unreported, and thus, the true incidence remains underestimated. [3] Radiodermatitis is classified into acute, subacute, and chronic. An episode of acute radiodermatitis increases the risk of developing chronic radiodermatitis. However, not all cases of acute reaction are followed by chronic injury. Likewise, chronic radiodermatitis may or may not be preceded by an acute phase. [1,2,4,6,9,10,] Frazier et al. reviewed 42 cases of FIRD reported in dermatology literature till 2007, of which 31 were of chronic, 3 were of subacute, and 9 were of acute FIRD. [6] The reason for low number of published cases of acute FIRD is more likely to be its mild self-limited course and is probable that only the severe cases of FIRD are reported. Acute radiodermatitis occurs within 90 days of radiation exposure. [1, 2] The reaction simulating a burn injury varies from erythema, dry to moist desquamation, blistering, ulceration, and necrosis. [1, 2, 11] Most cases are mild and are likely to heal. [1, 3] Histology resembles a phototoxic reaction characterized by pyknotic keratinocytes and intracellular epidermal edema. Dermal changes include edema, vascular dilation, hemorrhage, thrombi, and sparse inflammation. [11] [12] [13] Severe reactions show epidermal and dermal necrosis, blistering, and desquamation. [11] Subacute radiodermatitis occurs weeks to months after exposure and shows features overlapping with acute and chronic radiodermatitis. Clinically, it may mimic contact dermatitis, fixed drug eruption, dermatomyositis, morphea, and subacute cutaneous lupus erythematosus. [11] Histologically, an interface dermatitis with basal layer vacuolization and prominent apoptotic and some cytologically atypical keratinocytes are seen. A variably dense perivascular lymphohistiocytic infiltrate which may obscure dermoepidermal junction is present. Satellite cell necrosis characterized by lymphocytes in close apposition to apoptotic keratinocytes is notable. Histopathological features simulate graft versus host disease and fixed drug eruption. [11, 13] Chronic radiodermatitis occurs months to years after exposure. It may occur in the absence of any acute damage or after a variable latent period following acute changes. Thus, it is different from consequential late effects of persistent nonhealing severe acute radiodermatitis. [1] One of our cases (case 2) denied any history of preceding acute reaction, while in case 1, there was a history of acute radiation dermatitis. Chronic injury ranges from transient peau d'orange appearance and pigmentary changes which may resolve or worsen over time to persistent alterations such as loss of appendages; poikilodermatous changes including dyspigmentation, atrophy, and telangiectasia; ulceration; and fibrosis. [1, 2] Clinically, it may simulate morphea [10, 12, 14] and erythema ab igne. [10] Chronic radiodermatitis is usually permanent, progressive, and potentially irreversible. [1] Microscopic features are epidermal atrophy, hyperkeratosis, telangiectasia, loss of adnexa, fibrosis with homogenization of collagen, and atypical stellate radiation fibroblasts. [10] [11] [12] [13] Small arterioles and venules often show hyaline change in wall with narrowing of lumen. [13] The histopathological differential diagnosis includes morphea [4, 12, 14] and lichen sclerosus. [4, 14] Cutaneous malignancy including squamous and basal cell carcinomas has been documented in a small proportion of radiotherapy-related chronic radiodermatitis; [1, 13] however, only an occasional case of basal cell carcinoma has been reported as a consequence of FICRD. [9] The diagnosis of FIRD is challenging. In a review of 32 cases by Takikawa, 17 were misdiagnosed as herpes zoster, fixed drug eruption, scleroderma, decubitus ulcer, and trichophytosis. Sometimes, patients undergo multiple biopsies because of incorrect diagnosis. [15] Factors contributing to a delay in the diagnosis of FICRD include long latent period resulting in failure to attribute the lesion to prior procedure; localization mostly on back (thus remains unnoticed until well advanced); unfamiliarity of this entity among clinicians and pathologists; and clinicopathological resemblance to morphea. In six biopsied cases reported by Wei et al., in the absence of prior information about radiation exposure, a pathological diagnosis of radiodermatitis was made only in one case while four were misdiagnosed as morphea and one as chronic ulcer. [4] The diagnosis of FICRD should be suspected in the presence of a well-demarcated, geometric-, rectangular-, square-, or angular-shaped lesion at specific sites such as right or left scapular and subscapular regions, upper-mid back, right midaxillary area, and right anterolateral chest. [3, 4, 6, 10, 12] In contrast to morphea, chronic radiation dermatitis is frequently associated with pain, pruritus, ulceration, and telangiectasia. [3, 14] Histopathologically, the presence of radiation fibroblasts is pathognomonic of radiodermatitis. However, radiation fibroblasts may be sparse, and particularly, in the absence of clinical suspicion of radiodermatitis, this finding may be missed. [3] Additional clues are presence of hyperkeratosis and telangiectasia and lack of lymphocytic infiltrate in radiodermatitis. [12, 14] There is a loss of CD34+ dermal dendrocytes in morphea which are preserved in radiodermatitis albeit atypical fibroblasts are negative for CD34. [12] FICRD is often refractory to treatment and may require skin grafting. Awareness of FIRD and implementation of measures to minimize exposure are critical. Recommendations have been established for dose management and patient protection in fluoroscopic procedures. Biopsy should be avoided as it might trigger a nonhealing wound and secondary infection, but it may be necessary if the diagnosis is uncertain or to exclude development of malignancy. [3, 4] 
CONCLUSION
The diagnosis of FICRD requires high index of clinicopathological suspicion. The characteristic morphology and topography of the lesion and finding of radiation fibroblasts in a sclerodermoid background should alert the clinician and pathologist, respectively.
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